• New

Pisizif SR 1,5 mg. 30 tablets

€15
Tax included

The name of your medicine is Pisizif SR prolonged-release film-coated tablets. Their active ingredient is indapamide 1.5 mg (indapamide 1.5 mg). The tablets also contain several inactive substances, which are: lactose monohydrate, pregelatinized starch, hypromellose, colloidal silicon dioxide, magnesium stearate, macrogol 6000 and titanium dioxide.

Quantity

What is your medicine and what is it used for?

The name of your medicine is Pisizif SR (Pisizif SR) prolonged-release film-coated tablets. Their active ingredient is indapamide 1.5 mg (indapamide 1.5 mg). The tablets also contain several inactive substances, which are: lactose monohydrate, pregelatinized starch, hypromellose, colloidal silicon dioxide, magnesium stearate, macrogol 6000 and titanium dioxide.

Pisisif SR is an antihypertensive diuretic (non-thiazide sulfonamide) that is prescribed to treat high blood pressure (hypertension).

Before you start taking Pisisif SR

Do not take Pisisif SR if:

- if you are hypersensitive to indapamide or any of the other ingredients in the tablets

- if you are hypersensitive to sulphonamides.

- you have severe kidney failure

- you have serious liver disease

- hypokalaemia (abnormal decrease in plasma potassium levels)

- a recent cerebrovascular accident

Take special care with Pisisif SR if you have:

disturbed water-electrolyte balance

gout

diabetes

kidney problems

Your doctor may order laboratory tests to monitor your treatment.

If you have any further questions, ask your doctor or pharmacist.

Taking other medicines:

The combined use of Pisisif SR is not recommended with the following medicines:

- diuretics

- antiarrhythmics (quinidine, digoxin, corticosteroids or laxatives in case of hypokalaemia).

lithium (increase in blood levels due to decreased urinary excretion of

lithium)

To avoid possible interactions between different medicines, you should inform your doctor if you are taking any other medicines, including those without a prescription.

Pregnancy and lactation:

Tell your doctor if you are pregnant, want to become pregnant or breast-feeding. As a rule, during pregnancy or breastfeeding, it is advisable to seek advice from your doctor before taking any medicine.

Driving and using machines:

Individual reactions associated with lowering blood pressure may occur in some patients. Therefore, the ability to drive and use machines may be reduced.

Information for athletes:

Pisisif SR contains an active substance that may cause a positive reaction in an anti-doping control test.

List of excipients with established action or effect:

This medicinal product contains 144.22 mg of lactose monohydrate. When taken according to the dosing recommendations, each tablet provides 144.22 mg of lactose monohydrate. Not suitable for people with lactase deficiency, galactosemia or glucose / galactose malabsorption syndrome.

How to take Pisisif SR:

Always use Pisisif SR exactly as your doctor has told you. If you are not sure, talk to your doctor or pharmacist. The usual dose is 1 tablet a day.

Method of administration: It is administered orally.

Frequency and time of reception:

Only one dose for 24 hours, preferably in the morning, given the diuretic effect of the drug, in order to avoid the need to get up several times at night.

If you forget to take Pisisif SR

DO NOT take a double dose to make up for a forgotten dose.

Overdose

In case of accidental or intentional overdose, consult a doctor immediately.

Do not stop taking Pisisif SR before consulting your doctor. Possible side effects

Like all medicines, Pisisif SR can cause side effects, although not everybody gets them:

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Possible side effects are:

Feeling tired (asthenia)

Allergic reactions (hypersensitivity reactions) as well as rare cases of skin rash

Dizziness when moving quickly to an upright position

Increased risk of dehydration in elderly patients or in heart failure.

Changes in some blood parameters may occur especially in older patients or in those with malnutrition. Your doctor may request laboratory tests to monitor these parameters.

Storage conditions and shelf life

Store below 25 ° C.

Do not take after the expiry date stated on the pack.

Keep out of reach of children

Dosage form and quantity in one package:

One box contains 30 film-coated prolonged-release tablets in 3 blisters.

1000 Items